Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626912 · ClinicalTrials.gov registry record · Phase 4
PRET: Patients Prone to Recurrence After Endovascular Treatment
A Phase 4 study of Subarachnoid Hemorrhage and Intracranial Aneurysm, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Completed
- Registry status
- Phase 4
- Development phase
- 447
- Enrollment target
- 20
- Study locations
NCT00626912 is a Phase 4 study of Subarachnoid Hemorrhage and Intracranial Aneurysm that has completed, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 447 participants, below the 3,567-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT00626912, a Phase 4 study of Subarachnoid Hemorrhage and Intracranial Aneurysm, has completed, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 447 participants
- Enrollment target
- 20
- Study locations
Study Summary
The PRET study aims at comparing two types of coils used in the endovascular treatment of intracranial aneurysms. The first type made of platinum has been used for more than 15 years. The other, referred to as hydrocoil, containing in addition to platinum a polymer layer that expands when in contact with blood, has been in use since 2002. The hypothesis of the PRET study is that the newer hydrocoil will be more effective and yet as safe as the older platinum coil.
Conditions Studied
Interventions
- PROCEDURE endovascular coil embolization
Study Locations (20)
New York
- University of Buffalo (SUNY) - Buffalo
- Stony Brook University Medical Center (SUNY) - Stony Brook
- SUNY Upstate Medical University - Syracuse
Missouri
- Saint Francis Medical Center - Cape Girardeau
- Washington University in St Louis - St Louis
Ohio
- University of Cincinnati Medical Center - Cincinnati
- Cleveland Clinic - Cleveland
Florida
- Shands - University of Florida Hospital - Gainesville
Michigan
- Borgess Medical Center - Kalamazoo
Minnesota
- Mayo Clinic Rochester - Rochester
Mississippi
- University of Mississipi Health Care - Jackson
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2007-06 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626912
The ClinicalTrials.gov registry entry for NCT00626912 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,567-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (87% lower). The listed sponsor is Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which endovascular coil embolization is the first listed.
NCT00626912 reports 20 study locations spanning 16 distinct geographic areas - top geographies include New York, Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT00626912 about?
NCT00626912 is a clinical study titled "PRET: Patients Prone to Recurrence After Endovascular Treatment". The PRET study aims at comparing two types of coils used in the endovascular treatment of intracranial aneurysms. The first type made of platinum has been used for more than 15 years. The other, referred to as hydrocoil, containing in addition to platinum a polymer layer that expands when in contact...
What is the current status of trial NCT00626912?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 447 participants. The study started on 2007-06. Estimated completion is 2015-12.
What conditions does trial NCT00626912 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage, Intracranial Aneurysm.
What interventions are being tested in trial NCT00626912?
The interventions under investigation include: endovascular coil embolization (PROCEDURE).
Who is sponsoring clinical trial NCT00626912?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00626912 being conducted?
This trial has 20 study locations across Florida, Michigan, Minnesota, Mississippi, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System
COMPLETED · Phase 4
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Auricular VNS Following Subarachnoid Hemorrhage
RECRUITING · NA
-
Optical Coherence Tomography Angiography in Neurological Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.